173 related articles for article (PubMed ID: 34649947)
1. Antisense RNAs Influence Promoter Usage of Their Counterpart Sense Genes in Cancer.
Bellido Molias F; Sim A; Leong KW; An O; Song Y; Ng VHE; Lim MWJ; Ying C; Teo JXJ; Göke J; Chen L
Cancer Res; 2021 Dec; 81(23):5849-5861. PubMed ID: 34649947
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNAs Hepatocyte Nuclear Factor 4A Antisense RNA 1 and Hepatocyte Nuclear Factor 1A Antisense RNA 1 Are Involved in Ritonavir-Induced Cytotoxicity in Hepatoma Cells.
Wang X; Yu Y; Wang P; Yang K; Wang Y; Yan L; Zhong XB; Zhang L
Drug Metab Dispos; 2022 May; 50(5):704-715. PubMed ID: 34949673
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
5. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
6. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.
Niehof M; Borlak J
Gastroenterology; 2008 Apr; 134(4):1191-202. PubMed ID: 18395097
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma.
Guo C; Zhou S; Yi W; Yang P; Li O; Liu J; Peng C
Exp Mol Pathol; 2021 Jun; 120():104638. PubMed ID: 33878313
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma.
Jiang CF; Wen LZ; Yin C; Xu WP; Shi B; Zhang X; Xie WF
Oncotarget; 2016 May; 7(19):27408-21. PubMed ID: 27050273
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
[TBL] [Abstract][Full Text] [Related]
10. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
[TBL] [Abstract][Full Text] [Related]
11. A natural antisense transcript regulates acetylcholinesterase gene expression via epigenetic modification in Hepatocellular Carcinoma.
Xi Q; Gao N; Zhang X; Zhang B; Ye W; Wu J; Zhang X
Int J Biochem Cell Biol; 2014 Oct; 55():242-51. PubMed ID: 25240585
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.
Guo S; Lu H
J Cell Biochem; 2019 Jan; 120(1):519-532. PubMed ID: 30191603
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein.
Gao J; Dai C; Yu X; Yin XB; Zhou F
FASEB J; 2020 Apr; 34(4):5800-5817. PubMed ID: 32128906
[TBL] [Abstract][Full Text] [Related]
15. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
[TBL] [Abstract][Full Text] [Related]
16. HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of
Haque E; Teeli AS; Winiarczyk D; Taguchi M; Sakuraba S; Kono H; Leszczyński P; Pierzchała M; Taniguchi H
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327967
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
[TBL] [Abstract][Full Text] [Related]
18. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
19. Functional roles of antisense enhancer RNA for promoting prostate cancer progression.
Pan CW; Wen S; Chen L; Wei Y; Niu Y; Zhao Y
Theranostics; 2021; 11(4):1780-1794. PubMed ID: 33408781
[No Abstract] [Full Text] [Related]
20. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
